Hematological Parameters and Inflammatory Markers in Children with Multisystem Inflammatory Syndrome
Abstract Objective: Multisystem inflammatory syndrome in children (MIS-C), is a newly recognised life-threatening complication of coronavirus disease 2019 (COVID-19). Early determination of clinical severity of the disease is important for early decision of treatment regimens. The aim of this study...
Main Authors: | Gülsüm Alkan, Melike Emiroğlu, Şadiye Kübra Tüter Öz, Ahmet Sert |
---|---|
Format: | Article |
Language: | English |
Published: |
Selçuk University
2022-08-01
|
Series: | Genel Tıp Dergisi |
Subjects: | |
Online Access: | https://dergipark.org.tr/tr/download/article-file/2377438 |
Similar Items
-
Multisystem inflammatory syndrome in adults - In COVID-19
by: Vasantha Kamath, et al.
Published: (2023-01-01) -
MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DIAGNOSTIC MARKERS AND FEATURES OF PHARMACOTHERAPY
by: M.V. Кhaitovych, et al.
Published: (2021-03-01) -
Clinical Profile, Outcome, and Short-Term Follow-up of Pediatric Multisystem Inflammatory Syndrome Cases in a Tertiary Care Center of Western India
by: Qury Nagadia, et al.
Published: (2024-01-01) -
A single-center experience from Eastern India depicting the epidemiology and phenotypic variations of Multisystem inflammatory syndrome in children (MISC) associated with SARS-CoV2 seen after first wave and second wave of COVID 19
by: Mimi Ganguly, et al.
Published: (2023-01-01) -
Multisystem inflammatory syndrome in adults: Underdiagnosed??
by: T S Ravindra, et al.
Published: (2023-01-01)